Within3 Names Ian McKinnon, Ph.D., as Managing Director, Global Head of Consulting

Former Oracle leader joins to advance launch intelligence innovation

Within3, the leading Launch Intelligence™ platform for life science, today announced the appointment of Ian McKinnon, Ph.D., as Managing Director, Global Head of Consulting. McKinnon joins from Oracle, where he most recently served as Global Head of Commercial Consulting, Life Sciences.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251006813185/en/

Former Oracle leader brings 20+ years of pharma and biotech commercialization expertise to accelerate the growth of Within3’s Launch Intelligence™ platform and consulting services.

Former Oracle leader brings 20+ years of pharma and biotech commercialization expertise to accelerate the growth of Within3’s Launch Intelligence™ platform and consulting services.

With more than two decades of experience guiding pharmaceutical and biotech companies through complex commercialization challenges, McKinnon has held senior leadership roles at Oracle, Cerner, Kantar Health, and TNS Healthcare. His expertise spans launch excellence, evidence-based strategy, advanced analytics, and the application of AI and machine learning to real-world data.

“Bringing Ian on board is another signal of our ambition to redefine how life sciences organizations approach launch,” said Lance Hill, CEO of Within3. “Top industry leaders don’t leave Oracle to join just any company. Ian’s decision underscores the disruptive work we’re doing with Launch Intelligence™ and reinforces our reputation as the partner driving pharma’s next era of innovation.”

In his new role, McKinnon will accelerate the growth of Within3’s Launch Intelligence™ platform and services, ensuring clients capture maximum value from real-time, decision-ready insights. He will lead initiatives that help pharmaceutical brand, medical, and field teams unify fragmented data, anticipate market shifts, and act with confidence at every stage of launch. By combining deep commercialization expertise with Within3’s proprietary technology, McKinnon will help expand the company’s ability to deliver intelligence and guidance that enable life science organizations to launch with confidence.

“Joining Within3 is about being part of a visionary organization,” said McKinnon. “The company is building something that simply does not exist elsewhere in the industry, and it’s an opportunity to apply my experience to a team that is setting the pace for how launches succeed in pharma.”

This leadership appointment comes as Within3 continues rapid growth, expanding its Launch Intelligence™ platform and services to support pharmaceutical companies across the launch lifecycle.

About Within3

We help pharma teams make faster, smarter decisions by unifying the most critical sources of insight — including field activity, HCP engagement, social sentiment, claims data, congresses, and more — into a single, decision-ready view of the market. Powered by Know Everything™, Within3 accelerates time-to-insight and delivers precise, actionable intelligence that drives measurable impact across brand, medical, and field teams.

Trusted by all the top 20 pharmaceutical companies, Within3 enables life sciences organizations to move at the speed of launch — without sacrificing insight or clarity.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.